Serum biomarkers of exposure to perfluoroalkyl substances in relation to serum testosterone and measures of thyroid function among adults and adolescents from NHANES 2011–2012

International Journal of Environmental Research and Public Health

Volumn 12, Issue 6, 2015, Pages 6098-6114

  Lewis, Ryan C ^a   Johns, Lauren E ^a   Meeker, John D ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Biomarkers; Perfluoroalkyl substances; Testosterone; Thyroid function

Indexed keywords

COTININE; LIOTHYRONINE; PERFLEXANE; PERFLUORONONANOIC ACID; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; TESTOSTERONE; THYROTROPIN; THYROXINE; ALKANESULFONIC ACID; BIOLOGICAL MARKER; FLUOROCARBON; POLLUTANT;

ADOLESCENCE; ADULT; BIOMARKER; HORMONE; SERUM; TESTOSTERONE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; ENVIRONMENTAL EXPOSURE; ENZYME IMMUNOASSAY; FEMALE; HEALTH SURVEY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; SEX DIFFERENCE; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; TESTOSTERONE BLOOD LEVEL; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; VERY ELDERLY; BLOOD; CHILD; ENVIRONMENTAL MONITORING; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITION; POLLUTANT; STATISTICAL MODEL; YOUNG ADULT;

ANIMALIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALKANESULFONIC ACIDS; BIOMARKERS; CHILD; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; FEMALE; FLUOROCARBONS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITION SURVEYS; TESTOSTERONE; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE; YOUNG ADULT;

EID: 84930656377     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph120606098     Document Type: Article

References (62)

1. Hoffman, K.; Webster, T.F.; Weisskopf, M.G.; Weinberg, J.; Vieira, V.M. Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12–15 years of age. Environ. Health Perspect. 2010, 118, 1762–1767.
2. Calafat, A.M.; Wong, L.Y.; Kuklenyik, Z.; Reidy, J.A.; Needham, L.L. Polyfluoroalkyl chemicals in the U.S. population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003–2004 and comparisons with NHANES 1999–2000. Environ. Health Perspect. 2007, 115, 1596–1602.
3. Renner, R. Growing concern over perfluorinated chemicals. Environ. Sci. Technol. 2001, 35, 154–160.
4. Fromme, H.; Mosch, C.; Morovitz, M.; Alba-Alejandre, I.; Boehmer, S.; Kiranoglu, M.; Faber, F.; Hannibal, I.; Genzel-Boroviczény, O.; Koletzko, B. et al. Pre- and postnatal exposure to perfluorinated compounds (PFCs). Environ. Sci. Technol. 2010, 44, 7123–7129.
5. Lau, C.; Anitole, K.; Hodes, C.; Lai, D.; Pfahles-Hutchens, A.; Seed, J. Perfluoroalkyl acids: A review of monitoring and toxicological findings. Toxicol. Sci. 2007, 99, 366–394.
6. Kennedy, G.L., Jr.; Butenhoff, J.L.; Olsen, G.W.; O’Connor, J.C.; Seacat, A.M.; Perkins, R.G.; Biegel, L.B.; Murphy, S.R.; Farrar, D.G. The toxicology of perfluorooctanoate. Crit. Rev. Toxicol. 2004, 34, 351–384.
7. Andersen, M.E.; Butenhoff, J.L.; Chang, S.C.; Farrar, D.G.; Kennedy, G.L., Jr.; Lau, C.; Olsen, G.W.; Seed, J.; Wallace, K.B. Perfluoroalkyl acids and related chemistries—Toxicokinetics and modes of action. Toxicol. Sci. 2008, 102, 3–14.
8. 2010/2015. PFOA Stewardship Program. Available online: http://www.epa.gov/oppt/pfoa/pubs/stewardship/ (accessed on 10. April 2015).
9. Nelson, J.W.; Hatch, E.E.; Webster, T.F. Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population. Environ. Health Perspect. 2010, 118, 197–202.
10. Kato, K.; Wong, L.Y.; Jia, L.T.; Kuklenyik, Z.; Calafat, A.M. Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999–2008. Environ. Sci. Technol. 2011, 45, 8037–8045.
11. Blum, A.; Balan, S.A.; Scheringer, M.; Trier, X.; Goldenman, G.; Cousins, I.T.; Diamond, M.; Fletcher, T.; Higgins, C.; Lindeman, A.E. et al. The Madrid Statement on Poly- and Perfluoroalkyl Substances (PFASs). Environ. Health Perspect. 2015, 123, A107–A111.
12. Yialamas, M.A.; Hayes, F.J. Androgens and the ageing male and female. Best Pract. Res. Clin. Endocrinol. Metab. 2003, 17, 223–236.
13. Kumar, P.; Kumar, N.; Thakur, D.S.; Patidar, A. Male hypogonadism: Symptoms and treatment. J. Adv. Pharm. Technol. Res. 2010, 1, 297–301.
14. Mathur, R.; Braunstein, G.D. Androgen deficiency and therapy in women. Curr. Opin. Endocrinol. Diabetes Obes. 2010, 17, 342–349.
15. Joensen, U.N.; Veyrand, B.; Antignac, J.P.; Blomberg Jensen, M.; Petersen, J.H.; Marchand, P.; Skakkebæk, N.E.; Andersson, A.M.; Le Bizec, B.; Jørgensen, N. PFOS (perfluorooctanesulfonate) in serum is negatively associated with testosterone levels, but not with semen quality, in healthy men. Hum. Reprod. 2013, 28, 599–608.
16. Joensen, U.N.; Bossi, R.; Leffers, H.; Jensen, A.A.; Skakkebaek, N.E.; Jørgensen, N. Do perfluoroalkyl compounds impair human semen quality? Environ. Health Perspect. 2009, 117, 923–927.
17. Raymer, J.H.; Michael, L.C.; Studabaker, W.B.; Olsen, G.W.; Sloan, C.S.; Wilcosky, T.; Walmer, D.K. Concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) and their associations with human semen quality measurements. Reprod. Toxicol. 2012, 33, 419–427.
18. Specht, I.O.; Hougaard, K.S.; Spanò, M.; Bizzaro, D.; Manicardi, G.C.; Lindh, C.H.; Toft, G.; Jönsson, B.A.; Giwercman, A.; Bonde, J.P. Sperm DNA integrity in relation to exposure to environmental perfluoroalkyl substances—A study of spouses of pregnant women in three geographical regions. Reprod. Toxicol. 2012, 33, 577–583.
19. Ji, K.; Kim, S.; Kho, Y.; Paek, D.; Sakong, J.; Ha, J.; Kim, S.; Choi, K. Serum concentrations of major perfluorinated compounds among the general population in Korea: Dietary sources and potential impact on thyroid hormones. Environ. Int. 2012, 45, 78–85.
20. Lin, C.Y.; Wen, L.L.; Lin, L.Y.; Wen, T.W.; Lien, G.W.; Hsu, S.H.; Chien, K.L.; Liao, C.C.; Sung, F.C.; Chen, P.C. et al. The associations between serum perfluorinated chemicals and thyroid function in adolescents and young adults. J. Hazard. Mater. 2013, 15, 637–644.
21. Dallaire, R.; Dewailly, E.; Pereg, D.; Dery, S.; Ayotte, P. Thyroid function and plasma concentrations of polyhalogenated compounds in Inuit adults. Environ. Health Perspect. 2009, 117, 1380–1386.
22. Webster, G.M.; Venners, S.A.; Mattman, A.; Martin, J.W. Associations between perfluoroalkyl acids (PFASs) and maternal thyroid hormones in early pregnancy: A population-based cohort study. Environ. Res. 2014, 133, 338–347.
23. Jain, R.B. Association between thyroid profile and perfluoroalkyl acids: Data from NHANES 2007–2008. Environ. Res. 2013, 126, 51–59.
24. Wen, L.L.; Lin, L.Y.; Su, T.C.; Chen, P.C.; Lin, C.Y. Association between serum perfluorinated chemicals and thyroid function in U.S. adults: The National Health and Nutrition Examination Survey 2007–2010. J. Clin. Endocrinol. Metab. 2013, 98, 1456–1464.
25. NHANES 2011–2012. Overview. Available online: http://www.cdc.gov/nchs/nhanes/nhanes2011–2012/overview_g.htm (accessed on 15. February 2015).
26. National Health and Nutrition Examination Survey, 2011–2012. Data Documentation, Codebook, and Frequencies, Demographic Variables and Sample Weights. Available online: http://wwwn.cdc.gov/nchs/nhanes/2011–2012/DEMO_G.htm (accessed on 15. February 2015).
27. National Health and Nutrition Examination Survey, 2011–2012. Data Documentation, Codebook, and Frequencies, Body Measures. Available online: http://wwwn.cdc.gov/nchs/nhanes/2011–2012/BMX_G.htm (accessed on 15. February 2015).
28. Centers for Disease Control and Prevention. Laboratory Procedures Manual, Total Testosterone in Serum, NHANES 2011–2012; Centers for Disease Control and Prevention: Atlanta, GA, USA, 2015.
29. Centers for Disease Control and Prevention. Laboratory Procedures Manual, Cotinine in Serum, NHANES 2011–2012; Centers for Disease Control and Prevention: Atlanta, GA, USA, 2008.
30. Centers for Disease Control and Prevention. Laboratory Procedures Manual, Polyfluoroalkyl. Chemicals in Serum, NHANES 2011–2012; Centers for Disease Control and Prevention: Atlanta, GA, USA, 2013.
31. Centers for Disease Control and Prevention. Laboratory Procedures Manual, Thyroid Stimulating Hormone in Serum, NHANES 2011–2012. Centers for Disease Control and Prevention: Atlanta, GA, USA, 2015.
32. Korn, E.L.; Graubard, B.I. Epidemiologic studies utilizing surveys: Accounting for the sampling design. Am. J. Public Health 1991, 81, 1166–1173.
33. Silver, M.K.; Lozoff, B.; Meeker, J.D. Blood cadmium is elevated in iron deficient U.S. children: A cross-sectional study. Environ. Health 2013, 12, 117.
34. Lewis, R.C.; Meeker, J.D. Biomarkers of exposure to molybdenum and other metals in relation to testosterone among men from the United States National Health and Nutrition Examination Survey 2011–2012. Fertil. Steril. 2015, 103,172–178.
35. National Center for Health Statistics. National Health and Nutrition Examination Survey: Analytic Guidelines, 1999–2010; Centers for Disease Control and Prevention: Atlanta, GA, USA, 2013.
36. Meeker, J.D.; Ferguson, K.K. Urinary phthalate metabolites are associated with decreased serum testosterone in men, women, and children from NHANES 2011–2012. J. Clin. Endocrinol. Metab. 2014, 99, 4346–4352.
37. Brantsæter, A.L.; Whitworth, K.W.; Ydersbond, T.A.; Haug, L.S.; Haugen, M.; Knutsen, H.K.; Thomsen, C.; Meltzer, H.M.; Becher, G.; Sabaredzovic, A. et al. Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women. Environ. Int. 2013, 54, 74–84.
38. Inoue, K.; Okada, F.; Ito, R.; Kato, S.; Sasaki, S.; Nakajima, S.; Uno, A.; Saijo, Y.; Sata, F.; Yoshimura, Y.; Kishi, R.; Nakazawa, H. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: Assessment of PFOS exposure in a susceptible population during pregnancy. Environ. Health Perspect. 2004, 112, 1204–1207.
39. Cook, J.C.; Murray, S.M.; Frame, S.R.; Hurtt, M.E. Induction of Leydig cell adenomas by ammonium perfluorooctanoate: A possible endocrine-related mechanism. Toxicol. Appl. Pharmacol. 1992, 113, 209–217.
40. Biegel, L.B.; Liu, R.C.; Hurtt, M.E.; Cook, J.C. Effects of ammonium perfluorooctanoate on Leydig cell function: In vitro, in vivo, and ex vivo studies. Toxicol. Appl. Pharmacol. 1995, 134, 18–25.
41. Bookstaff, R.C.; Moore, R.W.; Ingall, G.B.; Peterson, R.E. Androgenic deficiency in male rats treated with perfluorodecanoic acid. Toxicol. Appl. Pharmacol. 1990, 104, 322–333.
42. Weber, G.; Vigone, M.C.; Stroppa, L.; Chiumello, G. Thyroid function and puberty. J. Pediatr. Endocrinol. Metab. 2003, 16, 253–257.
43. Bettendorf, M. Thyroid disorders in children from birth to adolescence. Eur. J. Nucl. Med. Mol. Imag. 2002, 29, S439–S446.
44. Doufas, A.G.; Mastorakos, G. The hypothalamic-pituitary-thyroid axis and the female reproductive system. Ann. N. Y. Acad. Sci. 2000, 900, 65–76.
45. Hu, Y.Y.; Li, G.M.; Hu, W.W.; Wang, Y. Characteristics of girls with pituitary hyperplasia and sexual precocity secondary to primary hypothyroidism. Acta Paediatr. 2014, 103, 43–48.
46. Traggiai, C.; Stanhope, R. Delayed puberty. Best Pract. Res.: Clin. Endocrinol. Metab. 2002, 16, 139–151.
47. Demartini, B.; Masu, A.; Scarone, S.; Pontiroli, A.E.; Gambini, O. Prevalence of depression in patients affected by subclinical hypothyroidism. Panminerva Med. 2010, 52, 277–282.
48. Rodondi, N.; den Elzen, W.P.; Bauer, D.C.; Cappola, A.R.; Razvi, S.; Walsh, J.P.; Asvold, B.O.; Iervasi, G.; Imaizumi, M.; Collet, T.H. et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. J. Am. Med. Assoc. 2010, 304, 1365–1374.
49. Hage, M.P.; Azar, S.T. The link between thyroid function and depression. J. Thyroid Res. 2012, 2012, doi:10.1155/2012/590648.
50. Wang C. The relationship between type 2 diabetes mellitus and related thyroid diseases. J. Diabetes Res. 2013, 2013, doi:10.1155/2013/390534.
51. Ren, X.M.; Zhang, Y.F.; Guo, L.H.; Qin, Z.F.; Lv, Q.Y.; Zhang, L.Y. Structure-activity relations in binding of perfluoroalkyl compounds to human thyroid hormone T3 receptor. Arch. Toxicol. 2015, 89, 233–242.
52. Melzer, D.; Rice, N.; Depledge, M.H.; Henley, W.E.; Galloway, T.S. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey. Environ. Health Perspect. 2010, 118, 686–692.
53. de Cock, M.; de Boer, M.R.; Lamoree, M.; Legler, J.; van de Bor, M. Prenatal exposure to endocrine disrupting chemicals in relation to thyroid hormone levels in infants—A Dutch prospective cohort study. Environ. Health 2014, 13, doi:10.1186/1476-069X-13-106.
54. Kim, S.; Choi, K.; Ji, K.; Seo, J.; Kho, Y.; Park, J.; Kim, S.; Park, S.; Hwang, I.; Jeon, J.; Yang, H.; Giesy, J.P. Trans-placental transfer of thirteen perfluorinated compounds and relations with fetal thyroid hormones. Environ. Sci. Technol. 2011, 45, 7465–7472.
55. Bloom, M.S.; Kannan, K.; Spliethoff, H.M.; Tao, L.; Aldous, K.M.; Vena, J.E. Exploratory assessment of perfluorinated compounds and human thyroid function. Physiol. Behav. 2010, 99, 240–245.
56. Chan, E.; Burstyn, I.; Cherry, N.; Bamforth, F.; Martin, J.W. Perfluorinated acids and hypothyroxinemia in pregnant women. Environ. Res. 2011, 111, 559–564.
57. Wang, C.; Catlin, D.H.; Demers, L.M.; Starcevic, B.; Swerdloff, R.S. Measurement of total serum testosterone in adult men: Comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. J. Clin. Endocrinol. Metab. 2004, 89, 534–543.
58. Boas, M.; Feldt-Rasmussen, U; Skakkebaek, N.E.; Main, K.M. Environmental chemicals and thyroid function. Eur. J. Endocrinol. 2006, 154, 599–611.
59. Gupta, S.K.; Lindemulder, E.A.; Sathyan, G. Modeling of circadian testosterone in healthy men and hypogonadal men. J. Clin. Pharmacol. 2000, 40, 731–738.
60. Brabant, G.; Prank, K; Hoang-Vu, C.; Hesch, R.D.; von zur Mühlen, A. Hypothalamic regulation of pulsatile thyrotopin secretion. J. Clin. Endocrinol. Metab. 1991, 72, 145–150.
61. Chang, S.C.; Thibodeaux, J.R.; Eastvold, M.L.; Ehresman, D.J.; Bjork, J.A.; Froehlich, J.W.; Lau, C.S.; Singh, R.J.; Wallace, K.B.; Butenhoff, J.L. Negative bias from analog methods used in the analysis of free thyroxine in rat serum containing perfluorooctanesulfonate (PFOS). Toxicology 2007, 234, 21–33.
62. Lopez-Espinosa, M.J.; Fitz-Simon, N.; Bloom, M.S.; Calafat, A.M.; Fletcher T. Comparison between free serum thyroxine levels, measured by analog and dialysis methods, in the presence of perfluorooctane sulfonate and perfluorooctanoate. Reprod. Toxicol. 2012, 33, 552–555.